Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: Four open-label, randomized crossover trials in healthy volunteers
References (11)
- et al.
Mechanisms of action and clinical characteristics of three atypical antidepressants: Venlafaxine, nefazodone, bupropion
J Affect Disord.
(1998) - et al.
Pharmacokinetics of once-daily venlafaxine extended release (ER) in healthy volunteers
Curr Ther Res Clin Exp.
(1997) (venlafaxine hydrochloride) extended-release capsules [package insert]
(2009)- et al.
Venlafaxine: A structurally unique and novel antidepressant
Ann Pharmacother
(1995) - et al.
Venlafaxine. A review of its pharmacology and therapeutic potential in depression
Drugs
(1995)
There are more references available in the full text version of this article.
Cited by (9)
Precision dosing of venlafaxine during pregnancy: a pharmacokinetics modelling approach
2024, Journal of Pharmacy and PharmacologyStudy on pharmacokinetics of osmotic pump tablets of hydrochloride venlafaxine in Chinese healthy volunteers
2022, Chinese Pharmacological BulletinCorrelation between pharmacokinetics and in vitro dissolution of terazosin hydrochloride capsules in Beagle dogs
2020, Chinese Journal of New DrugsPharmacokinetics and bioequivalence of Venlafaxine hydrochloride sustained release tablets in Beagle dogs
2019, Drug Evaluation ResearchAnti pharmaceutical patent ever-greening law: Global need in support of public health
2019, Journal of Intellectual Property RightsMolecular Salts of the Antidepressant Venlafaxine: An Effective Route to Solubility Properties Modifications
2017, Crystal Growth and Design
Copyright © 2009 Excerpta Medica Inc. All rights reserved.